Sanford Health:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanford Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3349
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox cosmetic, breast cancer risk consultation, 3D mammography, breast radiology, cancer risk assessment and cancer screenings, among others. It carries out research in cancer biology and immunotherapies, cellular therapies and stem cell biology, diabetes, enabling technologies, environmental influences on health and disease, genetics and genomics, pediatrics and rare diseases, population health. The center serves across the US. Sanford is headquartered in Sioux Falls, South Dakota, the US.

Sanford Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanford Health, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
InGeneron Raises USD20 Million in Series D Financing 11
Partnerships 12
Caladrius Biosciences Enters into Development Agreement with Sanford Research 12
Merger 13
Sanford Health Completes Merger With Medcenter One 13
Equity Offering 14
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 14
Caladrius Biosciences Raises USD6.6 Million in Private Placement of Shares 16
Acquisition 18
Sanford Health Acquires Hematech, Drug Development Company 18
Sanford Health Completes Acquisition Of Hillsboro Medical Center 19
Sanford Health – Key Competitors 20
Sanford Health – Key Employees 21
Sanford Health – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Recent Developments 24
Strategy And Business Planning 24
Jan 23, 2018: Sanford Health increases global presence with expansion in seven countries 24
Legal and Regulatory 25
Oct 20, 2017: FDA-approved clinical trial tests stem cells to heal wounds 25
Government and Public Interest 26
Sep 15, 2017: Sanford Health awarded $1.8 million to study brain tumors 26
Aug 18, 2017: Sanford Health granted $11 million to study population health 27
Product News 28
Dec 04, 2017: Breast cancer study uses personalized approach 28
Apr 20, 2017: Oncology group chooses Sanford for first clinical trial 29
Other Significant Developments 30
Apr 17, 2018: Personalized Medicine Initiatives Offer Hope To Acutely Ill Children At Nicklaus Children’s Hospital 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sanford Health, Pharmaceuticals & Healthcare, Key Facts 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9
Sanford Health, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InGeneron Raises USD20 Million in Series D Financing 11
Caladrius Biosciences Enters into Development Agreement with Sanford Research 12
Sanford Health Completes Merger With Medcenter One 13
Caladrius Biosciences Plans to Raise USD3.8 Million in Private Placement of Shares 14
Caladrius Biosciences Raises USD6.6 Million in Private Placement of Shares 16
Sanford Health Acquires Hematech, Drug Development Company 18
Sanford Health Completes Acquisition Of Hillsboro Medical Center 19
Sanford Health, Key Competitors 20
Sanford Health, Key Employees 21
Sanford Health, Other Locations 22
Sanford Health, Subsidiaries 23
Sanford Health, Joint Venture 23

List of Figures
Sanford Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanford Health, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanford Health, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanford Health, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanford Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanford Health, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sanford Health:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fonar Corp (FONR):企業の財務・戦略的SWOT分析
    Summary Fonar Corp (Fonar) is a medical device company that develops and manufacturers magnetic resonance imaging (MRI) scanners. The company provides products such as upright MRI, Fonar 360 and the open sky MRI. Fonar upright MRI is equipped with its MRI–compatible motorized patient handling system …
  • AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations. Its lead therapeutic candidate is a patient-specific immunotherapy f …
  • NEXTracker Inc:電力:M&Aディール及び事業提携情報
    Summary NEXTracker Inc (NEXTracker), a subsidiary of Flex Ltd, is a renewable energy company. The company is engaged in the design, development, and manufacture of single-axis solar trackers for the power plants. It offers services such as design and engineering, project management, installation, pe …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Datatec Ltd (DTC):企業の財務・戦略的SWOT分析
    Datatec Ltd (DTC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • NuvOx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NuvOx Pharma LLC (NuvOx Pharma) is a biotechnology company that develops oxygen therapeutics for the treatment of human diseases. The company develops novel therapies and formulations based on dodecafluoropentane emulsion platform. Its pipeline products include compounds such as NVX-108, NVX …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務情報
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • Milestone Scientific Inc (MLSS):製品パイプライン分析
    Summary Milestone Scientific Inc (Milestone Scientific) is a medical device company that designs, manufactures and distributes computer controlled drug delivery instruments. The company provides medical products and dental products. Its medical products include epidurals, intra-articular injections, …
  • Scheid Vineyards Inc:企業の戦略・SWOT・財務情報
    Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report Summary Scheid Vineyards Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析
    Summary San Raffaele hospital (San Raffaele), a subsidiary of Vita-Salute San Raffaele University is a clinical scientific university institution that offers education and healthcare services. The institute provides services through the segments clinic, scientific research, patient services, and hos …
  • Grupo Industrial Saltillo, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Industrial Saltillo, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Landesbank Berlin Holding Ag:企業の戦略・SWOT・財務分析
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Amtek Auto Limited:企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Fog Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fog Pharmaceuticals Inc (Fog Pharmaceuticals) is a clinical-stage biotechnology company that discovers and develops next-generation peptide inhibitors that target traditionally undruggable intracellular protein-protein interactions. The company develops cell-penetrating miniproteins (CPMPs), …
  • Inovise Medical, Inc.-医療機器分野:企業M&A・提携分析
    Summary Inovise Medical, Inc. (Inovise Medical) is a diagnostic medical technology company that develops technology for diagnosing and monitoring heart disease. The company offers cardiovascular monitoring devices, ECG monitoring equipment. Its product portfolio includes AUDICOR AM monitor, AUDICOR …
  • The Seibels Bruce Group, Inc:企業の戦略・SWOT・財務情報
    The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report Summary The Seibels Bruce Group, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Baoye Group Company Limited:企業の戦略・SWOT・財務情報
    Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report Summary Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆